PHAX expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.688800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.201200E-01
Normal-vs-Stage2
5.937800E-01
Normal-vs-Stage3
1.977170E-01
Normal-vs-Stage4
4.496800E-01
Stage1-vs-Stage2
3.807000E-01
Stage1-vs-Stage3
1.397190E-01
Stage1-vs-Stage4
3.338800E-01
Stage2-vs-Stage3
3.891600E-01
Stage2-vs-Stage4
2.455900E-02
Stage3-vs-Stage4
1.340570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.493400E-01
Normal-vs-AfricanAmerican
9.893800E-01
Normal-vs-Asian
5.032200E-01
Caucasian-vs-AfricanAmerican
5.126200E-01
Caucasian-vs-Asian
3.911000E-01
AfricanAmerican-vs-Asian
3.915600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.379600E-01
Normal-vs-Female
7.235200E-01
Male-vs-Female
6.037600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.124400E-01
Normal-vs-Age(41-60Yrs)
8.667000E-01
Normal-vs-Age(61-80Yrs)
5.093400E-01
Normal-vs-Age(81-100Yrs)
1.922160E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.006400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.537200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.088200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.722000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.362400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.062400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.637600E-01
Normal-vs-Daily Drinker
2.805200E-01
Normal-vs-Weekly Drinker
4.644200E-01
Normal-vs-Occasional Drinker
7.617600E-01
Normal-vs-Social Drinker
8.552200E-01
Non Drinker-vs-Daily Drinker
7.137800E-01
Non Drinker-vs-Weekly Drinker
9.122600E-01
Non Drinker-vs-Occasional Drinker
2.483900E-02
Non Drinker-vs-Social Drinker
2.135400E-01
Daily Drinker-vs-Weekly Drinker
6.936600E-01
Daily Drinker-vs-Occasional Drinker
1.921890E-02
Daily Drinker-vs-Social Drinker
1.438400E-01
Weekly Drinker-vs-Occasional Drinker
9.937600E-02
Weekly Drinker-vs-Social Drinker
3.692400E-01
Occasional Drinker-vs-Social Drinker
4.008800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.490000E-02
Normal-vs-Grade 2
3.080700E-03
Normal-vs-Grade 3
5.923800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.497800E-01
Grade 1-vs-Grade 3
2.947800E-01
Grade 1-vs-Grade 4
5.490000E-02
Grade 2-vs-Grade 3
6.222400E-01
Grade 2-vs-Grade 4
3.080700E-03
Grade 3-vs-Grade 4
5.923800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.971800E-01
Normal-vs-NonDiabetic
6.021200E-01
Diabetic-vs-NonDiabetic
9.227600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.104000E-01
Normal-vs-NoPancreatitis
6.742400E-01
Pancreatitis-vs-NoPancreatitis
3.896600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.426600E-01
Normal-vs-N1
6.323200E-01
N0-vs-N1
7.542600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.907000E-01
Normal-vs-TP53-NonMutant
8.617000E-01
TP53-Mutant-vs-TP53-NonMutant
8.956000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
